Cargando…

Drug use evaluation of Meropenem at a tertiary care university hospital: A report from Northern Iran

OBJECTIVE: The inappropriate use of antibiotics remains the primary factor in antimicrobial drug resistance. In this study, we evaluate the use of meropenem in surgical/medical wards of Imam Khomeini Tertiary Referral Hospital, Sari, Iran. METHODS: This retrospective observational study was used to...

Descripción completa

Detalles Bibliográficos
Autores principales: Salehifar, Ebrahim, Shiva, Afshin, Moshayedi, Mona, Kashi, Taravat Samiei, Chabra, Aroona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645136/
https://www.ncbi.nlm.nih.gov/pubmed/26645030
http://dx.doi.org/10.4103/2279-042X.167047
_version_ 1782400770275016704
author Salehifar, Ebrahim
Shiva, Afshin
Moshayedi, Mona
Kashi, Taravat Samiei
Chabra, Aroona
author_facet Salehifar, Ebrahim
Shiva, Afshin
Moshayedi, Mona
Kashi, Taravat Samiei
Chabra, Aroona
author_sort Salehifar, Ebrahim
collection PubMed
description OBJECTIVE: The inappropriate use of antibiotics remains the primary factor in antimicrobial drug resistance. In this study, we evaluate the use of meropenem in surgical/medical wards of Imam Khomeini Tertiary Referral Hospital, Sari, Iran. METHODS: This retrospective observational study was used to assess rational use of meropenem. The study was conducted by reviewing medical records of 100 admitted patients who received meropenem during March 2013 to January 2014. FINDINGS: Meropenem was prescribed most frequently in Intensive Care Unit (22%), and pneumonia was the most common diagnosis (35%). The third-generation cephalosporins were the most frequently prescribed antimicrobials after meropenem (53%). In 21% of the patients, imipenem was changed to meropenem. Most of the inappropriate uses were seen in terms of frequency of meropenem use (34%), followed by duration of meropenem therapy (28%). CONCLUSION: Comparing our study results has shown higher inappropriate use. It is necessary to take action to improve prescribing habit in order to reduce the unnecessary usage of antibiotic thus enhance rational antibiotic use.
format Online
Article
Text
id pubmed-4645136
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-46451362015-12-07 Drug use evaluation of Meropenem at a tertiary care university hospital: A report from Northern Iran Salehifar, Ebrahim Shiva, Afshin Moshayedi, Mona Kashi, Taravat Samiei Chabra, Aroona J Res Pharm Pract Clinical Study OBJECTIVE: The inappropriate use of antibiotics remains the primary factor in antimicrobial drug resistance. In this study, we evaluate the use of meropenem in surgical/medical wards of Imam Khomeini Tertiary Referral Hospital, Sari, Iran. METHODS: This retrospective observational study was used to assess rational use of meropenem. The study was conducted by reviewing medical records of 100 admitted patients who received meropenem during March 2013 to January 2014. FINDINGS: Meropenem was prescribed most frequently in Intensive Care Unit (22%), and pneumonia was the most common diagnosis (35%). The third-generation cephalosporins were the most frequently prescribed antimicrobials after meropenem (53%). In 21% of the patients, imipenem was changed to meropenem. Most of the inappropriate uses were seen in terms of frequency of meropenem use (34%), followed by duration of meropenem therapy (28%). CONCLUSION: Comparing our study results has shown higher inappropriate use. It is necessary to take action to improve prescribing habit in order to reduce the unnecessary usage of antibiotic thus enhance rational antibiotic use. Medknow Publications & Media Pvt Ltd 2015 /pmc/articles/PMC4645136/ /pubmed/26645030 http://dx.doi.org/10.4103/2279-042X.167047 Text en Copyright: © Journal of Research in Pharmacy Practice http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Clinical Study
Salehifar, Ebrahim
Shiva, Afshin
Moshayedi, Mona
Kashi, Taravat Samiei
Chabra, Aroona
Drug use evaluation of Meropenem at a tertiary care university hospital: A report from Northern Iran
title Drug use evaluation of Meropenem at a tertiary care university hospital: A report from Northern Iran
title_full Drug use evaluation of Meropenem at a tertiary care university hospital: A report from Northern Iran
title_fullStr Drug use evaluation of Meropenem at a tertiary care university hospital: A report from Northern Iran
title_full_unstemmed Drug use evaluation of Meropenem at a tertiary care university hospital: A report from Northern Iran
title_short Drug use evaluation of Meropenem at a tertiary care university hospital: A report from Northern Iran
title_sort drug use evaluation of meropenem at a tertiary care university hospital: a report from northern iran
topic Clinical Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645136/
https://www.ncbi.nlm.nih.gov/pubmed/26645030
http://dx.doi.org/10.4103/2279-042X.167047
work_keys_str_mv AT salehifarebrahim druguseevaluationofmeropenematatertiarycareuniversityhospitalareportfromnortherniran
AT shivaafshin druguseevaluationofmeropenematatertiarycareuniversityhospitalareportfromnortherniran
AT moshayedimona druguseevaluationofmeropenematatertiarycareuniversityhospitalareportfromnortherniran
AT kashitaravatsamiei druguseevaluationofmeropenematatertiarycareuniversityhospitalareportfromnortherniran
AT chabraaroona druguseevaluationofmeropenematatertiarycareuniversityhospitalareportfromnortherniran